✦ LIBER ✦

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

✍ Scribed by G. G. Kimmick; C. Cirrincione; D. B. Duggan; K. Bhalla; N. Robert; D. Berry; L. Norton; S. Lemke; I. C. Henderson; C. Hudis; E. Winer; On Behalf of the Cancer and Leukemia Group B

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 325 KB
Volume: 113
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-008-9943-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views